Beyond Facial Wrinkles: 5 Internal Factors Accelerating Biological Aging
Aging is an inevitable biological process, but the rate at which it occurs is largely within individual control.
Search results for "Cancer"
Spatial Mapping of Residual Esophageal Cancer Reveals Genetic Clues to Recurrence Risk
Researchers have identified key genetic markers that could help estimate the risk of recurrence in esophageal cancer patients who have residual tumor...
Found a Breast Lump? Why Immediate Mammotome Removal Isn't Always the First Step
While lying on the ultrasound examination table, hearing the doctor say, "I see a lump here," instantly triggers...
Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters
Lung cancer is the second most commonly diagnosed cancer in South Korea and the leading cause of cancer mortality,...
97-Year-Old Gastric Cancer Patient Undergoes Total Stomach Removal via Robotic Surgery at Seoul St. Mary’s Hospital
For nonagenarian patients and their families, deciding whether to undergo major surgery presents a formidable dilemma.
Constipation, Colon Cancer, and the Trap of Zero-Fiber Diets: Why 'Complete Protein' Is a Misleading Myth
(Continued from installments 142 and 143) Animal protein is frequently described as a "complete protein" because it...
Asan Medical Center Ranks Six Specialties in World’s Top 10 in Newsweek 2027 Evaluation, Led by No. 2 Endocrinology
Asan Medical Center placed six specialties in the global top 10 of Newsweek’s “World’s Best Specialized Hospitals 2027”...
Samsung Medical Center Ranks No. 5 Globally for Cancer Care in Newsweek 2027 Assessment, Climbing to No. 12 in Respiratory Medicine
Samsung Medical Center has been named the No. 5 hospital worldwide and No. 1 in South Korea for cancer treatment,...
Why Nearly 4,000 Women Develop Liver Cancer Each Year—Even Without Heavy Drinking
Many people still assume liver cancer is primarily caused by alcohol consumption. While heavy drinking is certainly a...
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...